AU4973800A - Combination for treating weight gain associated with antipsychotic use comprising an atypical antipsychotic and an h2 antagonist - Google Patents
Combination for treating weight gain associated with antipsychotic use comprising an atypical antipsychotic and an h2 antagonistInfo
- Publication number
- AU4973800A AU4973800A AU49738/00A AU4973800A AU4973800A AU 4973800 A AU4973800 A AU 4973800A AU 49738/00 A AU49738/00 A AU 49738/00A AU 4973800 A AU4973800 A AU 4973800A AU 4973800 A AU4973800 A AU 4973800A
- Authority
- AU
- Australia
- Prior art keywords
- antipsychotic
- antagonist
- combination
- weight gain
- gain associated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 229940122957 Histamine H2 receptor antagonist Drugs 0.000 title 1
- 230000000561 anti-psychotic effect Effects 0.000 title 1
- 239000003693 atypical antipsychotic agent Substances 0.000 title 1
- 229940127236 atypical antipsychotics Drugs 0.000 title 1
- 239000003485 histamine H2 receptor antagonist Substances 0.000 title 1
- 230000004584 weight gain Effects 0.000 title 1
- 235000019786 weight gain Nutrition 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13831599P | 1999-06-09 | 1999-06-09 | |
| US60138315 | 1999-06-09 | ||
| PCT/US2000/009811 WO2000074784A1 (en) | 1999-06-09 | 2000-05-22 | Combination for treating weight gain associated with antipsychotic use comprising an atypical antipsychotic and an h2 antagonist |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU4973800A true AU4973800A (en) | 2000-12-28 |
Family
ID=22481488
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU49738/00A Abandoned AU4973800A (en) | 1999-06-09 | 2000-05-22 | Combination for treating weight gain associated with antipsychotic use comprising an atypical antipsychotic and an h2 antagonist |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP1189662A1 (en) |
| AU (1) | AU4973800A (en) |
| WO (1) | WO2000074784A1 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2856596B1 (en) * | 2003-06-27 | 2007-04-27 | Bioprojet Soc Civ | NOVEL PSYCHIATRIC DRUG ASSOCIATION AND THE USE OF AN INVERSE HISTAMINE H3 RECEPTOR ANTAGONIST OR AGONIST TO PREPARE A MEDICAMENT PREVENTING ADVERSE EFFECTS OF PSYCHOTROPES. |
| CA2622696A1 (en) * | 2007-11-05 | 2009-05-05 | Diane Mcintosh | Methods and compositions for retarding weight gain associated with use of atypical antipsychotic drugs |
| HK1215170A1 (en) | 2012-11-14 | 2016-08-19 | The Johns Hopkins University | Methods and compositions for treating schizophrenia |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ235877A (en) * | 1989-11-02 | 1992-09-25 | Mcneil Ppc Inc | Composition comprising acetaminophen or nsaid and an h 1 or h 2 receptor blocker and/or proton pump inhibitor for treating overindulgence |
| AU8194991A (en) * | 1990-07-06 | 1992-02-04 | Smithkline Beecham Plc | Use of cimetidine for weight loss |
| US5070101A (en) * | 1991-02-14 | 1991-12-03 | Mount Sinai School Of Medicine Of The City University Of New York | Method and pharmaceutical composition for the treatment of schizophrenia |
| US5508384A (en) * | 1992-09-10 | 1996-04-16 | New York University | Polypeptide derived from a popamine receptor, and compositions and methods thereof |
| ZA977967B (en) * | 1996-09-23 | 1999-03-04 | Lilly Co Eli | Combination therapy for treatment of psychoses |
| GB9901809D0 (en) * | 1999-01-27 | 1999-03-17 | Scarista Limited | Highly purified ethgyl epa and other epa derivatives for psychiatric and neurological disorderes |
-
2000
- 2000-05-22 AU AU49738/00A patent/AU4973800A/en not_active Abandoned
- 2000-05-22 EP EP00931932A patent/EP1189662A1/en not_active Withdrawn
- 2000-05-22 WO PCT/US2000/009811 patent/WO2000074784A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP1189662A1 (en) | 2002-03-27 |
| WO2000074784A1 (en) | 2000-12-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU4850400A (en) | The maize rs81 promoter and methods for use thereof | |
| ZA200203316B (en) | New use and novel n-azabicyclo-amide derivatives. | |
| GB9904503D0 (en) | Combination desk and chair | |
| AU7734700A (en) | Macrocyclic quinazolinones and their use as local anesthetics | |
| HU0002792D0 (en) | Triazole and imidazole derivatives | |
| AU7065200A (en) | Putting improvement devices and methods | |
| AU1006401A (en) | Device for supporting and stabilizing an injured person | |
| IL146629A0 (en) | Indolylpiperidine derivatives as antihistaminic and antiallergic agents | |
| AU1303301A (en) | Body weight gain inhibitors | |
| GB2349433B (en) | Sliding bearing and sliding bearing structure | |
| AU4493200A (en) | Retractable load-bearing cover | |
| AU4973800A (en) | Combination for treating weight gain associated with antipsychotic use comprising an atypical antipsychotic and an h2 antagonist | |
| AU5861900A (en) | Receptor agonists and antagonists | |
| AU1660201A (en) | Biglycan and related therapeutics and methods of use | |
| AU2001291877A1 (en) | N-alkoxyalkyl-substituted benzimidazoles and the use thereof as an agent againstparasitic protozoans | |
| AU2041901A (en) | Genes essential for microbial proliferation and antisense thereto | |
| AU4328700A (en) | Pseudomycin antifungal compositions and methods for their use | |
| AU7308300A (en) | Agents for reducing cholesterol-uptake and liquid-uptake | |
| AU2669201A (en) | Taccalonolides and their use | |
| AU2559100A (en) | An umbrella and container for an umbrella | |
| GB9920670D0 (en) | Stabilisation of peroxidases | |
| TW438174U (en) | Charger set structure suitable for both microphone and transmitter | |
| AU5424099A (en) | Rail with integrated supports | |
| AUPQ043799A0 (en) | Direct reduction with hydrogen | |
| GB9922392D0 (en) | Adjustable butt hinge |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |